Results 191 to 200 of about 39,213 (240)

Modulation of tocotrienol's bone effects by osteocytes: a perspective. [PDF]

Front Pharmacol
Zahanordin NN, Ng PY, Chin KY.
europepmc   +1 more source

HuR Knockdown in MLO-Y4 Osteocyte-like Cells Elevates OPG Expression and Suppresses Osteoclastogenesis In Vitro. [PDF]

Int J Mol Sci
Fan Z, Kitaura H, Marahleh A, Mousa A, Ohori F, Craevschi A, Rashad S, Kanetaka H.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Osteoprotegerin

Ortopedia, traumatologia, rehabilitacja, 2012
In 1997, a glycoprotein was isolated that blocked osteoclast differentiation from precursor cells. This protein prevented osteoporosis when administered to ovariectomized rats, and led to osteopetrosis when overexpressed. This newly discovered protein was named osteoprotegerin (OPG).
Marleen A. Baak, Bernard Gutin, Kim A. Krawczewski Carhuatanta, Stephen C. Woods, Heinz W. Harbach, Megan M. Wenner, Nina S. Stachenfeld, Timothy M. Griffin, Romain Meeusen, Kevin Pauw, Axel Urhausen, Li Li Ji, David C. Poole, Steven W. Copp, Daniel M. Hirai, Timothy I. Musch   +15 more
openaire   +3 more sources

Osteoprotegerin in diabetic osteopathy

Nutrition, Metabolism and Cardiovascular Diseases, 2020
The aim of this study is to evaluate the relationship between OPG and the degree of glycaemic control in a population of elderly subjects.Data presented included 172 elderly subjects, of whom 107 were hospitalized for a hip fracture and 65 were non fractured outpatients.
Valentini A., Cianfarani M. A., Federici M., Tarantino U., Bertoli A.   +4 more
openaire   +3 more sources

The effect of osteoprotegerin nanocomplex on osteoprotegerin and arteriosclerosis in mice

Materials Express, 2023
Osteoprotegerin (OPG), as one of the tumor necrosis factor receptors, is believed to be related with Osteoprotegerin (OP) and arteriosclerosis (AS). This study aims to explore the effect of OPG on osteoblasts (OB) and AS. The nanocomplex Poly(ethylene glycol)-Poly(L-Lysine)-Osteoprotegerin (PPO) was prepared by introducing OPG plasmid to Poly(ethylene ...
Zhiwen He, Shuang Wang, Xiaoxuan Xia
openaire   +1 more source

Osteoprotegerin and Diabetic Macroangiopathy

Hormone and Metabolic Research, 2005
Osteoprotegerin (OPG) is a bone-related protein that is also present in the vasculature. Recent data suggest that it may play a special role in arterial disease among patients with diabetes. Diabetic macroangiopathy is characterized by a series of diffuse, non-atherosclerotic alterations that hypothetically increase the vulnerability of the vessel wall
Rasmussen, Lars Melholt, Ledet, Thomas
openaire   +3 more sources

Osteoprotegerin and kidney disease

Journal of Nephrology, 2014
Vascular calcification in chronic kidney disease (CKD) patients is associated to increased mortality. Osteoprotegerin (OPG) is a soluble tumor necrosis factor (TNF) superfamily receptor that inhibits the actions of the cytokines receptor activator of nuclear factor kappa-B ligand (RANKL) and TNF-related apoptosis-inducing ligand (TRAIL) by preventing ...
Alejandra, Montañez-Barragán, Isaias, Gómez-Barrera, Maria D, Sanchez-Niño, Alvaro C, Ucero, Liliana, González-Espinoza, Alberto, Ortiz   +5 more
openaire   +2 more sources